(VCTR) Victory Capital Holdings - Overview
Stock: Mutual Funds, ETFs, Separate Accounts, Alternative Investments, 529 Plans
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.96% |
| Yield on Cost 5y | 9.08% |
| Yield CAGR 5y | 38.32% |
| Payout Consistency | 100.0% |
| Payout Ratio | 42.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.5% |
| Relative Tail Risk | -2.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -7.56 |
| Character TTM | |
|---|---|
| Beta | 1.312 |
| Beta Downside | 1.361 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.06% |
| CAGR/Max DD | 1.36 |
Description: VCTR Victory Capital Holdings January 09, 2026
Victory Capital Holdings Inc. (NASDAQ: VCTR) is a U.S.–based asset manager that delivers a broad suite of investment solutions-including active and passive mutual funds, ETFs, separate accounts, variable insurance products, alternative strategies, private closed-end funds, and a 529 education savings plan-to institutional clients, retirement platforms, intermediaries, and retail investors. The firm also distributes third-party products and provides ancillary services such as fund administration, transfer-agent, and distribution support.
As of the most recent filing (FY 2023), Victory reported approximately $100 billion in assets under management (AUM), representing a 7 % year-over-year increase driven largely by net inflows into its actively managed equity and fixed-income funds. The company’s revenue mix is roughly 65 % fee-based and 35 % performance-based, reflecting the industry-wide shift toward lower-cost passive products and heightened fee compression pressure. A key macro driver for Victory’s outlook is the Federal Reserve’s interest-rate policy: higher rates tend to boost demand for fixed-income solutions while also increasing the cost of capital for leveraged alternative strategies.
For a deeper, data-rich perspective on Victory Capital’s valuation and risk profile, you might find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 294.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -5.38 > 1.0 |
| NWC/Revenue: 12.01% < 20% (prev 10.64%; Δ 1.37% < -1%) |
| CFO/TA 0.08 > 3% & CFO 332.2m > Net Income 294.2m |
| Net Debt (903.3m) to EBITDA (522.2m): 1.73 < 3 |
| Current Ratio: 1.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (67.0m) vs 12m ago 1.37% < -2% |
| Gross Margin: 61.24% > 18% (prev 0.58%; Δ 6066 % > 0.5%) |
| Asset Turnover: 34.12% > 50% (prev 33.19%; Δ 0.94% > 0%) |
| Interest Coverage Ratio: 7.15 > 6 (EBITDA TTM 522.2m / Interest Expense TTM 64.8m) |
Altman Z'' 2.52
| A: 0.03 (Total Current Assets 305.5m - Total Current Liabilities 165.7m) / Total Assets 4.21b |
| B: 0.24 (Retained Earnings 1.03b / Total Assets 4.21b) |
| C: 0.14 (EBIT TTM 463.4m / Avg Total Assets 3.41b) |
| D: 0.57 (Book Value of Equity 1.04b / Total Liabilities 1.81b) |
| Altman-Z'' Score: 2.52 = A |
Beneish M -2.58
| DSRI: 1.29 (Receivables 168.5m/96.9m, Revenue 1.16b/866.9m) |
| GMI: 0.94 (GM 61.24% / 57.69%) |
| AQI: 1.03 (AQ_t 0.91 / AQ_t-1 0.88) |
| SGI: 1.34 (Revenue 1.16b / 866.9m) |
| TATA: -0.01 (NI 294.2m - CFO 332.2m) / TA 4.21b) |
| Beneish M-Score: -2.58 (Cap -4..+1) = A |
What is the price of VCTR shares?
Over the past week, the price has changed by +1.02%, over one month by +6.34%, over three months by +16.42% and over the past year by +11.77%.
Is VCTR a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VCTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 71.5 | 0.4% |
| Analysts Target Price | 71.5 | 0.4% |
| ValueRay Target Price | 93.4 | 31.1% |
VCTR Fundamental Data Overview February 03, 2026
P/E Forward = 10.1215
P/S = 4.0453
P/B = 1.8883
Revenue TTM = 1.16b USD
EBIT TTM = 463.4m USD
EBITDA TTM = 522.2m USD
Long Term Debt = 972.0m USD (from longTermDebt, last quarter)
Short Term Debt = 7.36m USD (from shortTermDebt, last quarter)
Debt = 1.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 903.3m USD (from netDebt column, last quarter)
Enterprise Value = 5.61b USD (4.71b + Debt 1.02b - CCE 115.7m)
Interest Coverage Ratio = 7.15 (Ebit TTM 463.4m / Interest Expense TTM 64.8m)
EV/FCF = 17.09x (Enterprise Value 5.61b / FCF TTM 328.5m)
FCF Yield = 5.85% (FCF TTM 328.5m / Enterprise Value 5.61b)
FCF Margin = 28.21% (FCF TTM 328.5m / Revenue TTM 1.16b)
Net Margin = 25.27% (Net Income TTM 294.2m / Revenue TTM 1.16b)
Gross Margin = 61.24% ((Revenue TTM 1.16b - Cost of Revenue TTM 451.4m) / Revenue TTM)
Gross Margin QoQ = 71.18% (prev 70.55%)
Tobins Q-Ratio = 1.33 (Enterprise Value 5.61b / Total Assets 4.21b)
Interest Expense / Debt = 1.66% (Interest Expense 16.9m / Debt 1.02b)
Taxrate = 25.32% (32.7m / 129.3m)
NOPAT = 346.1m (EBIT 463.4m * (1 - 25.32%))
Current Ratio = 1.84 (Total Current Assets 305.5m / Total Current Liabilities 165.7m)
Debt / Equity = 0.42 (Debt 1.02b / totalStockholderEquity, last quarter 2.40b)
Debt / EBITDA = 1.73 (Net Debt 903.3m / EBITDA 522.2m)
Debt / FCF = 2.75 (Net Debt 903.3m / FCF TTM 328.5m)
Total Stockholder Equity = 1.78b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.62% (Net Income 294.2m / Total Assets 4.21b)
RoE = 16.50% (Net Income TTM 294.2m / Total Stockholder Equity 1.78b)
RoCE = 16.82% (EBIT 463.4m / Capital Employed (Equity 1.78b + L.T.Debt 972.0m))
RoIC = 12.59% (NOPAT 346.1m / Invested Capital 2.75b)
WACC = 9.06% (E(4.71b)/V(5.73b) * Re(10.75%) + D(1.02b)/V(5.73b) * Rd(1.66%) * (1-Tc(0.25)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.02%
[DCF Debug] Terminal Value 73.96% ; FCFF base≈334.8m ; Y1≈327.9m ; Y5≈333.1m
Fair Price DCF = 61.22 (EV 4.88b - Net Debt 903.3m = Equity 3.98b / Shares 64.9m; r=9.06% [WACC]; 5y FCF grow -3.01% → 2.90% )
EPS Correlation: -14.10 | EPS CAGR: -47.93% | SUE: -4.0 | # QB: 0
Revenue Correlation: 58.55 | Revenue CAGR: 12.91% | SUE: -0.56 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.61 | Chg30d=-0.007 | Revisions Net=-4 | Analysts=6
EPS next Year (2026-12-31): EPS=6.88 | Chg30d=-0.048 | Revisions Net=-3 | Growth EPS=+10.3% | Growth Revenue=+16.0%